COMMUNIQUÉS West-GlobeNewswire

PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
16/04/2018
SALT LAKE CITY, April 16, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]
Photocure ASA: Annual accounts 2017
16/04/2018
Oslo, 16 April 2018: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2017. The annual accounts and annual report for the financial year 2017 are enclosed with this [...]
Photocure ASA: Notice of the annual general meeting 9 May 2018
16/04/2018
Oslo, 16 April 2018: Photocure ASA (OSE: PHO), calls for the annual general meeting of PHO to be held at Hoffsveien 4, 1 st floor, 0275 Oslo, Norway on 9 May 2018 at 17:00 hours (CET). The notice convening the general [...]
Apellis Pharmaceuticals Provides Update on Phase 1b Open Label Study of APL-2 in PNH Patients Not Previously Treated with Eculizumab
16/04/2018
Interim data shows broad hematologic correction including improved hemoglobin levels and reduction in LDH CRESTWOOD, Ky. and WALTHAM, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS [...]
Novo Nordisk A/S - Share repurchase programme
16/04/2018
Bagsværd, Denmark, 16 April 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccine’s Proprietary Delivery Platform
16/04/2018
Preclinical Data Presented at AACR Highlight the Novel Mechanism of Action Underscoring the Company’s T cell-Activating Technology HALIFAX, Nova Scotia, April 16, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV [...]
Aptevo Therapeutics’ Bispecific Antibody APVO436 Shows Robust T-Cell Activation With Minimal Cytokine Release
16/04/2018
New Preclinical Data Presented at the 2018 American Association for Cancer Research Annual Meeting Show Potent T-Cell Directed Tumor Killing with Reduced Cytokine Production Compared to a Competitor Bispecific Construct [...]
OrthoPediatrics Corp. Honored as One of the Best Places to Work in Indiana for a Second Year
16/04/2018
WARSAW, Ind., April 16, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named as [...]
Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting
16/04/2018
CAMBRIDGE, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ) today presented nonclinical and clinical data on DKN-01, Leap’s anti-DKK1 monoclonal antibody, at the American Association for [...]
Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing Imprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives Innate and Adaptive Immune Responses in Tumors
16/04/2018
EAGAN, Minn., April 16, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced the presentation of new translational data from ongoing phase 2 clinical trials combining Biothera’s Imprime PGG with [...]
TESARO Summarizes TSR-042 Clinical Data Presented at AACR
16/04/2018
Activity of TSR-042 (anti-PD-1 antibody) monotherapy demonstrated in patients with MSI-high endometrial and non-small cell lung cancers Data support unique and convenient dosing schedule Regulatory submission for TSR- [...]
SELLAS Life Sciences Reports Corporate Highlights, Advancements for its Cancer Immunotherapy Pipeline and 2017 Financial Results
16/04/2018
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc. (Nasdaq: SLS ) (“SELLAS”), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018
16/04/2018
Late-breaking poster demonstrates EC17/CAR T-cell therapy showed consistent antitumor activity in human xenografts with multiple mechanisms for controlling immune response WEST LAFAYETTE, Ind., April 16, 2018 (GLOBE [...]
BeiGene Presents Clinical Data on Pamiparib in Chinese Patients with Ovarian Cancers or Triple-Negative Breast Cancer at the American Association for Cancer Research Annual Meeting
16/04/2018
BEIJING, China and CAMBRIDGE, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
16/04/2018
TEL AVIV, Israel, April 16, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ: VBLT ) today presented a late-breaking study demonstrating a novel bi-specific antibody that induces immune-cell mediated killing of cancer [...]
Advantis Corp. Increased Revenue Over Eight Fold in 2017, Expects Revenue to Rise
16/04/2018
NEWPORT BEACH, CA , April 16, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) released its annual financial report, revealing the revenue increase of a company on the rise. 2017 revenue was $406,000 vs. $ [...]
Cannabix Technologies Files FAIMS Cannabis Detection Patent - Enters into License Agreement with University of Florida and Provides Technology Update
16/04/2018
The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. ( [...]
Regalia® CG Biofungicide Cleared for Use on Cannabis by the Colorado, Oregon, Washington and Nevada Departments of Agriculture
16/04/2018
Trials Show Regalia® CG to be an Effective Method of Powdery Mildew Control in Cannabis and Hemp DAVIS, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider [...]
Kallelse till årsstämma för C-RAD AB (publ)
16/04/2018
Aktie ä garna i C-RAD AB (publ), org. nr 556663-9174 ( ” Bolaget ” ), kallas h ä rmed till å rsst ä mma torsdagen den 17 maj 2018 klockan 10.00 p å Clarion Hotel Gillet, Dragarbrunnsgatan 23 i Uppsala. Rätt att deltaga [...]

Pages